- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Aliada Therapeutics Inc.
Headquarters: Boston, MA, United States
Website: N/A
Year Founded: 2021
Status: Acquired
BioCentury | Nov 5, 2024
Discovery & Translation
New frontiers in extracellular protein degradation
Six papers detail improved ways to degrade cell-surface cancer proteins through the lysosome
BioCentury | Oct 29, 2024
Deals
Novartis adds another degrader, this time from Monte Rosa
Deals report: AbbVie acquires Aliada, Roche returns tau mAb to UCB, Monopar licenses AZ’s Wilson disease program, and more
BioCentury | Oct 28, 2024
Deals
In $1.4B Aliada buy, AbbVie sees value in CNS delivery tech, as well as lead asset
Together, blood-brain barrier transport technology and Phase I Alzheimer’s therapy drive rare 10-figure early-stage takeout
BioCentury | Oct 2, 2024
Management Tracks
IGM names Mary Beth Harler CEO as it prioritizes T cell engagers
Plus: Ken Mills becomes CEO of Tagworks, and updates from AstronauTx, Trevi, Thrive and Madrigal
BioCentury | Jul 30, 2024
Product Development
Venturing beyond AAVs and LNPs to deliver therapeutic cargo
Dozens of companies aim to avoid immunogenicity and improve tissue-specificity
Items per page:
1 - 5 of 5